Results

RDF/XMLNTriplesTurtleShow queryShare ▶
SubjectPredicateObject
http://purl.uniprot.org/citations/26250833http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/26250833http://www.w3.org/2000/01/rdf-schema#comment"

Background

The cystic fibrosis (CF) transmembrane conductance regulator (CFTR) gating mutation G551D prevents sufficient ion transport due to reduced channel-open probability. Ivacaftor, an oral CFTR potentiator, increases the channel-open probability.

Aim

To further analyze improvements in weight and body mass index (BMI) in two studies of ivacaftor in patients aged ≥6 years with CF and the G551D mutation.

Methods

Patients were randomized 1:1 to ivacaftor 150 mg or placebo every 12 h for 48 weeks. Primary end point (lung function) was reported previously. Other outcomes included weight and height measurements and CF Questionnaire-Revised (CFQ-R).

Results

Studies included 213 patients (aged ≤ 20 years, n = 105; aged > 20 years, n = 108). In patients ≤20 years, adjusted mean change from baseline to week 48 in body weight was 4.9 versus 2.2 kg (ivacaftor vs. placebo, p = 0.0008). At week 48, change from baseline in mean weight-for-age z-score was 0.29 versus -0.06 (p < 0.0001); change in mean BMI-for-age z-score was 0.26 versus -0.13 (p < 0.0001). In patients >20 years, adjusted mean change from baseline to week 48 in body weight was 2.7 versus -0.2 kg (p = 0.0003). Mean BMI change at week 48 was 0.9 versus -0.1 kg/m(2) (p = 0.0003). There was no linear correlation evident between changes in body weight and improvements in lung function or sweat chloride. Significant CFQ-R improvements were seen in perception of eating, body image, and sense of ability to gain weight.

Conclusions

Nutritional status improved following treatment with ivacaftor for 48 weeks."xsd:string
http://purl.uniprot.org/citations/26250833http://purl.org/dc/terms/identifier"doi:10.1007/s10620-015-3834-2"xsd:string
http://purl.uniprot.org/citations/26250833http://purl.uniprot.org/core/author"Lubarsky B."xsd:string
http://purl.uniprot.org/citations/26250833http://purl.uniprot.org/core/author"Borowitz D."xsd:string
http://purl.uniprot.org/citations/26250833http://purl.uniprot.org/core/author"Munck A."xsd:string
http://purl.uniprot.org/citations/26250833http://purl.uniprot.org/core/author"Wilschanski M."xsd:string
http://purl.uniprot.org/citations/26250833http://purl.uniprot.org/core/author"Bodewes F."xsd:string
http://purl.uniprot.org/citations/26250833http://purl.uniprot.org/core/author"Gelfond D."xsd:string
http://purl.uniprot.org/citations/26250833http://purl.uniprot.org/core/author"Schwarzenberg S.J."xsd:string
http://purl.uniprot.org/citations/26250833http://purl.uniprot.org/core/date"2016"xsd:gYear
http://purl.uniprot.org/citations/26250833http://purl.uniprot.org/core/name"Dig Dis Sci"xsd:string
http://purl.uniprot.org/citations/26250833http://purl.uniprot.org/core/pages"198-207"xsd:string
http://purl.uniprot.org/citations/26250833http://purl.uniprot.org/core/title"Nutritional Status Improved in Cystic Fibrosis Patients with the G551D Mutation After Treatment with Ivacaftor."xsd:string
http://purl.uniprot.org/citations/26250833http://purl.uniprot.org/core/volume"61"xsd:string
http://purl.uniprot.org/citations/26250833http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/26250833
http://purl.uniprot.org/citations/26250833http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/26250833
http://purl.uniprot.org/uniprot/#_A0A089NFM8-mappedCitation-26250833http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/26250833
http://purl.uniprot.org/uniprot/#_A0A089PPW6-mappedCitation-26250833http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/26250833
http://purl.uniprot.org/uniprot/#_A0A088T1A1-mappedCitation-26250833http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/26250833
http://purl.uniprot.org/uniprot/#_A0A096ZUB9-mappedCitation-26250833http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/26250833
http://purl.uniprot.org/uniprot/#_A0A096ZUC0-mappedCitation-26250833http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/26250833
http://purl.uniprot.org/uniprot/#_A0A096ZUC4-mappedCitation-26250833http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/26250833
http://purl.uniprot.org/uniprot/#_A0A096ZUH4-mappedCitation-26250833http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/26250833
http://purl.uniprot.org/uniprot/#_A0A096ZUB3-mappedCitation-26250833http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/26250833
▶